ATG2B and laryngeal carcinoma: The global study of susceptibility in laryngeal cancer (Table 3) showed an association between the heterozygote genotype of ATG2B rs3759601 and a lower risk to develop laryngeal squamous cell carcinoma, p = 0.049 OR = 0.607 (0.369–0.999).